AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
VARIABILITY OF CONCENTRATIONS AFTER RECTAL PARACETAMOL
Authors: ANDERSON BJ MONTELEONE J HOLFORD NHG
Citation: Bj. Anderson et al., VARIABILITY OF CONCENTRATIONS AFTER RECTAL PARACETAMOL, Paediatric anaesthesia, 8(3), 1998, pp. 274-274
PARACETAMOL PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS IN CHILDREN
Authors: ANDERSON BJ HOLFORD NHG WOOLLARD GA CHAN PLS
Citation: Bj. Anderson et al., PARACETAMOL PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS IN CHILDREN, British journal of clinical pharmacology, 46(3), 1998, pp. 237-243
FEATURES AND TOXICOKINETICS OF CLOZAPINE IN OVERDOSE
Authors: REITH D MONTELEONE JPR WHYTE IM EBELLING W HOLFORD NHG CARTER GL
Citation: D. Reith et al., FEATURES AND TOXICOKINETICS OF CLOZAPINE IN OVERDOSE, Therapeutic drug monitoring, 20(1), 1998, pp. 92-97
SIMULATION-BASED EVALUATION OF AN ENRICHMENT TRIAL DESIGN FOR ALZHEIMERS-DISEASE
Authors: HOLFORD NHG
Citation: Nhg. Holford, SIMULATION-BASED EVALUATION OF AN ENRICHMENT TRIAL DESIGN FOR ALZHEIMERS-DISEASE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 110-110
RECTAL ACETAMINOPHEN PHARMACOKINETICS
Authors: ANDERSON BJ HOLFORD NHG
Citation: Bj. Anderson et Nhg. Holford, RECTAL ACETAMINOPHEN PHARMACOKINETICS, Anesthesiology, 88(4), 1998, pp. 1131-1131
RECTAL PARACETAMOL DOSING REGIMENS - DETERMINATION BY COMPUTER-SIMULATION
Authors: ANDERSON BJ HOLFORD NHG
Citation: Bj. Anderson et Nhg. Holford, RECTAL PARACETAMOL DOSING REGIMENS - DETERMINATION BY COMPUTER-SIMULATION, Paediatric anaesthesia, 7(6), 1997, pp. 451-455
COMPLEX PK PD MODELS - AN ALCOHOLIC EXPERIENCE/
Authors: HOLFORD NHG
Citation: Nhg. Holford, COMPLEX PK PD MODELS - AN ALCOHOLIC EXPERIENCE/, International journal of clinical pharmacology and therapeutics, 35(10), 1997, pp. 465-468
MECHANISMS OF ENHANCEMENT OF THE ANTITUMOR-ACTIVITY OF MELPHALAN BY THE TUMOR-BLOOD-FLOW INHIBITOR 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID
Authors: PRUIJN FB VANDAALEN M HOLFORD NHG WILSON WR
Citation: Fb. Pruijn et al., MECHANISMS OF ENHANCEMENT OF THE ANTITUMOR-ACTIVITY OF MELPHALAN BY THE TUMOR-BLOOD-FLOW INHIBITOR 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID, Cancer chemotherapy and pharmacology, 39(6), 1997, pp. 541-546
UNTITLED
Authors: HOLFORD NHG
Citation: Nhg. Holford, UNTITLED, Clinical pharmacokinetics, 33(6), 1997, pp. 401-402
SIZE, MYTHS AND THE CLINICAL PHARMACOKINETICS OF ANALGESIA IN PEDIATRIC-PATIENTS
Authors: ANDERSON BJ MCKEE AD HOLFORD NHG
Citation: Bj. Anderson et al., SIZE, MYTHS AND THE CLINICAL PHARMACOKINETICS OF ANALGESIA IN PEDIATRIC-PATIENTS, Clinical pharmacokinetics, 33(5), 1997, pp. 313-327
ASPECTS OF THEOPHYLLINE CLEARANCE IN CHILDREN
Authors: ANDERSON BJ HOLFORD NHG WOOLLARD GA
Citation: Bj. Anderson et al., ASPECTS OF THEOPHYLLINE CLEARANCE IN CHILDREN, Anaesthesia and intensive care, 25(5), 1997, pp. 497-501
RELATIONSHIP OF MUSCLE STRENGTH TO POTASSIUM CONCENTRATION IN A HYPOKALEMIC INFANT
Authors: REID AW ANDERSON BJ FUTTER ME HOLFORD NHG
Citation: Aw. Reid et al., RELATIONSHIP OF MUSCLE STRENGTH TO POTASSIUM CONCENTRATION IN A HYPOKALEMIC INFANT, Anaesthesia and intensive care, 25(5), 1997, pp. 525-527
THE RESPONSE TO LEVODOPA IN PARKINSONS-DISEASE - IMPOSING PHARMACOLOGICAL LAW-AND-ORDER
Authors: NUTT JG HOLFORD NHG
Citation: Jg. Nutt et Nhg. Holford, THE RESPONSE TO LEVODOPA IN PARKINSONS-DISEASE - IMPOSING PHARMACOLOGICAL LAW-AND-ORDER, Annals of neurology, 39(5), 1996, pp. 561-573
FROM THE EDITOR
Authors: HOLFORD NHG
Citation: Nhg. Holford, FROM THE EDITOR, Clinical pharmacokinetics, 31(6), 1996, pp. 407-409
A SIZE STANDARD FOR PHARMACOKINETICS
Authors: HOLFORD NHG
Citation: Nhg. Holford, A SIZE STANDARD FOR PHARMACOKINETICS, Clinical pharmacokinetics, 30(5), 1996, pp. 329-332
PHARMACOKINETICS OF RECTAL PARACETAMOL AFTER MAJOR SURGERY IN CHILDREN
Authors: ANDERSON BJ WOOLARD GA HOLFORD NHG
Citation: Bj. Anderson et al., PHARMACOKINETICS OF RECTAL PARACETAMOL AFTER MAJOR SURGERY IN CHILDREN, Paediatric anaesthesia, 5(4), 1995, pp. 237-242
PLASMA NITRATE CLEARANCE IN MICE - MODELING OF THE SYSTEMIC PRODUCTION OF NITRATE FOLLOWING THE INDUCTION OF NITRIC-OXIDE SYNTHESIS
Authors: VESZELOVSZKY E HOLFORD NHG THOMSEN LL KNOWLES RG BAGULEY BC
Citation: E. Veszelovszky et al., PLASMA NITRATE CLEARANCE IN MICE - MODELING OF THE SYSTEMIC PRODUCTION OF NITRATE FOLLOWING THE INDUCTION OF NITRIC-OXIDE SYNTHESIS, Cancer chemotherapy and pharmacology, 36(2), 1995, pp. 155-159
UNTITLED
Authors: HOLFORD NHG
Citation: Nhg. Holford, UNTITLED, Clinical pharmacokinetics, 29(6), 1995, pp. 393-395
THE TARGET CONCENTRATION APPROACH TO CLINICAL DRUG DEVELOPMENT
Authors: HOLFORD NHG
Citation: Nhg. Holford, THE TARGET CONCENTRATION APPROACH TO CLINICAL DRUG DEVELOPMENT, Clinical pharmacokinetics, 29(5), 1995, pp. 287-291
INPUT FROM THE DEEP SOUTH COMPARTMENT - A PERSONAL VIEWPOINT
Authors: HOLFORD NHG
Citation: Nhg. Holford, INPUT FROM THE DEEP SOUTH COMPARTMENT - A PERSONAL VIEWPOINT, Clinical pharmacokinetics, 29(3), 1995, pp. 139-141
POPULATION PHARMACODYNAMICS OF ROMAZARIT
Authors: HOLFORD NHG WILLIAMS PEO MUIRHEAD GJ MITCHELL A YORK A
Citation: Nhg. Holford et al., POPULATION PHARMACODYNAMICS OF ROMAZARIT, British journal of clinical pharmacology, 39(3), 1995, pp. 313-320
MOCLOBEMIDE - RELATIONSHIPS BETWEEN DOSE, DRUG CONCENTRATION IN PLASMA, AND OCCURRENCE OF ADVERSE EVENTS
Authors: GUENTERT TW BANKEN L HILTON S HOLFORD NHG
Citation: Tw. Guentert et al., MOCLOBEMIDE - RELATIONSHIPS BETWEEN DOSE, DRUG CONCENTRATION IN PLASMA, AND OCCURRENCE OF ADVERSE EVENTS, Journal of clinical psychopharmacology, 15(4), 1995, pp. 84-94
POPULATION PHARMACOKINETICS OF ETHANOL IN HUMANS - INFLUENCE OF DOSE,MEALS, H2-ANTAGONISTS, RACE AND ETHANOL USE
Authors: HOLFORD NHG FRASER A
Citation: Nhg. Holford et A. Fraser, POPULATION PHARMACOKINETICS OF ETHANOL IN HUMANS - INFLUENCE OF DOSE,MEALS, H2-ANTAGONISTS, RACE AND ETHANOL USE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 216-216
MIXED LINEAR AND NONLINEAR DISPOSITION OF LAZABEMIDE, A REVERSIBLE AND SELECTIVE INHIBITOR OF MONOAMINE-OXIDASE-B
Authors: GUENTERT TW HOLFORD NHG PFEFEN JP DINGEMANSE J
Citation: Tw. Guentert et al., MIXED LINEAR AND NONLINEAR DISPOSITION OF LAZABEMIDE, A REVERSIBLE AND SELECTIVE INHIBITOR OF MONOAMINE-OXIDASE-B, British journal of clinical pharmacology, 37(6), 1994, pp. 545-551
PHARMACODYNAMICS OF LAZABEMIDE, A REVERSIBLE AND SELECTIVE INHIBITOR OF MONOAMINE-OXIDASE-B
Authors: HOLFORD NHG GUENTERT TW DINGEMANSE J KETTLER R
Citation: Nhg. Holford et al., PHARMACODYNAMICS OF LAZABEMIDE, A REVERSIBLE AND SELECTIVE INHIBITOR OF MONOAMINE-OXIDASE-B, British journal of clinical pharmacology, 37(6), 1994, pp. 553-557
Risultati: 1-25 | 26-27